Mahmood I - Search Results

1

Integration of in vitro data and brain weight in allometric scaling to predict clearance in humans: some suggestions.

Mahmood I. Mahmood I. J Pharm Sci. 1998 Apr;87(4):527-9; discussion 530. doi: 10.1021/js9702628. J Pharm Sci. 1998. PMID: 9548910 No abstract available.

2

Interspecies scaling: a comparative study for the prediction of clearance and volume using two or more than two species.

Mahmood I, Balian JD. Mahmood I, et al. Life Sci. 1996;59(7):579-85. doi: 10.1016/0024-3205(96)00339-6. Life Sci. 1996. PMID: 8761347

3

Interspecies scaling: predicting clearance of drugs in humans. Three different approaches.

Mahmood I, Balian JD. Mahmood I, et al. Xenobiotica. 1996 Sep;26(9):887-95. doi: 10.3109/00498259609052491. Xenobiotica. 1996. PMID: 8893036 Review.

4

Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance.

Mahmood I, Balian JD. Mahmood I, et al. J Pharm Sci. 1996 Apr;85(4):411-4. doi: 10.1021/js950400y. J Pharm Sci. 1996. PMID: 8901079

5

Interspecies scaling: predicting clearance of anticancer drugs in humans. A comparative study of three different approaches using body weight or body surface area.

Mahmood I. Mahmood I. Eur J Drug Metab Pharmacokinet. 1996 Jul-Sep;21(3):275-8. doi: 10.1007/BF03189726. Eur J Drug Metab Pharmacokinet. 1996. PMID: 8980928

6

Pharmacokinetic analysis of the absorption characteristics of diclofenac sodium in man by use of a multi-segment absorption model.

Mahmood I. Mahmood I. J Pharm Pharmacol. 1996 Dec;48(12):1260-3. doi: 10.1111/j.2042-7158.1996.tb03933.x. J Pharm Pharmacol. 1996. PMID: 9004188 Clinical Trial.

7

A limited sampling method for the estimation of flunarizine area under the curve (AUC) and maximum plasma concentration (Cmax).

Mahmood I, Sahlroot JT. Mahmood I, et al. Biopharm Drug Dispos. 1997 Mar;18(2):117-26. doi: 10.1002/(sici)1099-081x(199703)18:2<117::aid-bdd5>3.0.co;2-c. Biopharm Drug Dispos. 1997. PMID: 9099448 Clinical Trial.

8

A comparative computer simulation study of three different sparse-sampling methods for the estimation of steady-state area under the concentration-time curve (AUC) and maximum concentration (Cmax) in toxicokinetics.

Mahmood I. Mahmood I. J Pharm Sci. 1997 May;86(5):579-83. doi: 10.1021/js960450i. J Pharm Sci. 1997. PMID: 9145382

9

Clinical pharmacokinetics and pharmacodynamics of selegiline. An update.

Mahmood I. Mahmood I. Clin Pharmacokinet. 1997 Aug;33(2):91-102. doi: 10.2165/00003088-199733020-00002. Clin Pharmacokinet. 1997. PMID: 9260033 Review.

10

A limited sampling approach in bioequivalence studies.

Mahmood I, Chamberlin N, Tammara V. Mahmood I, et al. Ther Drug Monit. 1997 Aug;19(4):413-9. doi: 10.1097/00007691-199708000-00009. Ther Drug Monit. 1997. PMID: 9263382 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results